Onsdag 28 Oktober | 21:11:41 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

IRRAS - Sales traction demonstrated in Q4 but stressed financials

2022-02-17 10:00:00

Redeye has a positive outlook on IRRAS sales development, but financial burdens are evident in the report. Its pressing financial situation overshadows any commercial progress at this point and needs to be sorted in order to attract interest to the stock. We adjust our fair value range, assuming an equity issue shortly.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/